Navigation Links
PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share
Date:12/2/2009

INCLINE VILLAGE, Nev., Dec. 2 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that it has established the per share amount of the previously announced $200 million special dividend as $1.67 per share. The dividend will be paid on December 15, 2009 to all holders of the Company's stock as of the December 1, 2009 record date. NASDAQ had previously estimated the approximate per share amount of the dividend at $1.67 per share of common stock for purposes of the ex-dividend date on November 27, 2009.

Conversion Rate Adjustments for Convertible Notes

In connection with this special dividend payment PDL has adjusted the conversion rates of its 2.00% Convertible Senior Notes Due February 15, 2012 (the 2012 Notes) and its 2.75% Convertible Subordinated Notes Due August 16, 2023 (the 2023 Notes), effective December 2, 2009.

The conversion rate for the 2012 Notes, as adjusted, is 119.294 shares of common stock per $1,000 principal amount or $8.38 per share. The conversion rate for the 2012 Notes was previously 94.447 shares of common stock per $1,000 principal amount of the 2012 Notes. In connection with a cash dividend, the conversion rate is increased by multiplying the previous conversion rate by a fraction, the numerator of which is the average closing price of PDL's common stock for the five consecutive trading days immediately preceding the ex-dividend date for the cash dividend, and the denominator of which is the difference of such average closing price less the dividend amount.

The conversion rate for the 2023 Notes, as adjusted, is 164.7254 shares of common stock per $1,000 principal amount or $6.07 per share. The conversion rate for the 2023 Notes was previously 131.0339 shares of common stock per $1,000 principal amount of the 2023 Notes. In connection with
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
2. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
3. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
4. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
5. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
8. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
9. Immunosyn Announces Biozyme Labs Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF-1019
10. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
11. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014 The new report ... (products, applications, techniques, end users and Geography) Global ... 2013 - 2020," indicates that the global DNA ... registering a CAGR of 9.8% from 2014 to ... cost effectiveness over alternative diagnostic techniques are factors ...
(Date:8/28/2014)... 2014  Seres Health, a clinical-stage therapeutics company ... human microbiome, announced today that Dr. David ... and Chief Scientific Officer, will be presenting at ... Chemotherapy (ICAAC). The presentation will highlight the scientific ... of bacterial spores derived from the human microbiome, ...
(Date:8/28/2014)... -- Gateway Analytical announced today that they will ... Global Pharma Manufacturing Summit in Boston, ... Global Pharma Manufacturing Summit offers a networking opportunity ... pharmaceutical manufacturing. The conference is focused on helping ... as the increasing pressure to grow and evolve ...
Breaking Medicine Technology:DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3Seres Health to Present Clinical Findings at ICAAC 2014 Conference 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3
(Date:8/29/2014)... the Fed reported an increase in industrial production ... 0.4% while manufacturing output progressed to 1.0%. , This ... February this year. Capacity use has increased by more than ... increase that could be attributed to the boost in vehicle ... a measure of slack across the industries. , Output in ...
(Date:8/29/2014)... Only a handful of CPR and basic life ... which are consistent with recent health guidelines, according ... Medicine Australasia , the journal for the Australasian ... recognition and treatment of sudden cardiac arrest are ... of Turkish emergency medicine specialists put together the ...
(Date:8/29/2014)... 2014 As a chiropractic physician and ... that there’s a direct connection between the condition of ... back. "Since conventional shoe inserts and orthotics weren’t satisfying ... my own," he said. , Customizable to a user’s ... for the foot in order to help prevent pain ...
(Date:8/29/2014)... FRIDAY, Aug. 29, 2014 (HealthDay News) -- Researchers have ... in their brains. Dyslexia -- the most commonly ... problems with reading and writing. Previous research showed ... but most of those studies focused only on a ... used functional MRI to analyze how multiple brain regions ...
(Date:8/29/2014)... Angeles (PRWEB) August 29, 2014 ... Radio Today at http://www.blogtalkradio.com/dr-carol-francis/2014/08/29/psychologist-dr-carol-francis-addressing-empty-nest-syndrome .     , Mothers ... years of money, marital bliss, prodding, laughing and ... of the house this week. Relief and ... of “now what.” Dr. Carol Francis ...
Breaking Medicine News(10 mins):Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 2Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 3Health News:Scientists Find Differences in Brains of Those With Dyslexia 2Health News:Psychologist Dr. Carol Francis Addressing Empty-Nest Syndrome on Talk Radio Today 2Health News:Psychologist Dr. Carol Francis Addressing Empty-Nest Syndrome on Talk Radio Today 3
... MPH, an endocrinologist at Nationwide Children,s Hospital, has developed ... text messages to remind adolescent diabetes patients about their ... Dr. Dyer found an increase in overall treatment adherence ... began developing this pilot study after realizing the potential ...
... Reporter , THURSDAY, July 29 (HealthDay News) -- Although ... and ward off osteoporosis, New Zealand researchers say the supplements ... small increase in the risk for heart attack among older ... researchers suggest that people get their required calcium, if possible, ...
... CD74 is a protein that is expressed in and ... lymphocytes and antigen presenting cells. This protein is known ... immune response. Additionally, Professor Shachar,s lab has previously shown ... of the immune system, and that its stimulation by ...
... important factor, influencing both morbidity and recovery after ... allow early intervention, which may prevent later complications. ... medical evaluations to identify significant weight loss over ... thickness, serum nutritional factor levels and functional measurements ...
... (HCC) is one of the most common cancers ... of the more difficult cancers to treat. It ... A number of dietary compounds possess anti-cancer properties. ... specific targets that control cell proliferation and apoptosis. ...
... clinical medicine are familiar with learning curves, and strategies ... on clinical care. Because similar learning curves have been ... University Medical Center studied the phenomenon in the data ... point to ways to improve the quality of future ...
Cached Medicine News:Health News:Pilot study supports adolescent diabetes patients through personalized text messages 2Health News:Calcium Supplements Linked to Boost in Heart Attack Risk 2Health News:Calcium Supplements Linked to Boost in Heart Attack Risk 3Health News:Calcium Supplements Linked to Boost in Heart Attack Risk 4Health News:How to detect malnutrition in patients effectively? 2Health News:Clinical trials can be improved by managing the learning curve 2Health News:Clinical trials can be improved by managing the learning curve 3
... Vacuum Controller V-800 Efficiently controls vacuum levels ... and off as needed to maintain preset vacuum level ... membrane vacuum pump designed to handle most vacuum applications. ... up to two rotary evaporators Laboratory vacuum ...
... V-500 and water-cooled secondary condenser to trap ... powerful PTFE membrane vacuum pump designed to ... Ideally suited for use with up ... vacuum source for instruments including vacuum ovens, ...
Universal vacuum pump (capacity 34 L/min, 8 mbar vacuum abs.)...
... addition to the powerful PTFE membrane vacuum pump ... achieve an ultimate vacuum of 1 mbar or ... For use with vacuum drying ovens ... from lab size up to industrial size rotary ...
Medicine Products: